Improving neuroendocrine cancer care amongst GPs SPONSORED: The disease is more prevalent than ovarian and brain cancer, but many medical professionals still don’t know the symptoms.
Study calls for population-wide genomic screening Expanded testing for three genetic conditions could save lives and money, Monash University research suggests.
Landmark Australian Cancer Plan hailed as ‘a new era’ GPs are expected to play a major role in a new 10-year blueprint Cancer Australia says will transform care across the country.
Consider MHT for bones: New menopause guideline Almost a decade in the making, a toolkit refresh is the first to include advice on prescribing hormone therapy specifically for bone health.
In Practice: NDIS information sessions The NDIA is running online information sessions throughout November to help GPs navigate changes to the early childhood approach.
Age drop for bowel cancer screening endorsed The NHMRC has approved guidelines to widen the age of bowel cancer screening, although the Federal Government is yet to sign off the change.
Brain health and risk reduction: The GP’s role If dementia risk factors can be targeted in early and mid-life, GPs have an opportunity to make a real difference, writes Dr Steph Daly.
Raising dementia awareness through collaboration GPs need to be better equipped with risk reduction tools and to help support patients with dementia, writes Dr Marita Long.
In Practice: Interim prohibition orders The RACGP has provided a generally supportive submission to AHPRA regarding its new power to issue IPOs.
GPs crucial to rare cancer care: RACGP Key reforms are needed to help GPs better diagnose and treat patients, according to the college’s submission to a Senate Inquiry.